Skip to content
WeighLab

MedLeanRx vs Intimate Rose

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MedLeanRx

Provider comparison

Texas residents who want a named supervising physician and a brand-name option alongside compounded GLP-1s.

Semaglutide / month
$149/moCompounded oral
Tirzepatide / month
$269/moCompounded
Index 58/100 · Grade CChecked August 2026

Intimate Rose

Provider comparison

Existing Intimate Rose customers who want to evaluate its OpenLoop-supported weight-management program and will compare the exact prescribed plan.

Semaglutide / month
Not separately disclosed (GLP-1 program from $169/mo)
Tirzepatide / month
Not disclosed
Index 58/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 58/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

MedLeanRx
1 state
Intimate Rose
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MedLeanRx

Intimate Rose

Semaglutide / month
MedLeanRx: $149/moCompounded oral
Intimate Rose: Not separately disclosed (GLP-1 program from $169/mo)
Tirzepatide / month
MedLeanRx: $269/moCompounded
Intimate Rose: Not disclosed
Semaglutide / year (modeled)
MedLeanRx: $1,788
Intimate Rose: —
Tirzepatide / year (modeled)
MedLeanRx: $3,228
Intimate Rose: —
State availability
MedLeanRx: 1 state
Intimate Rose: Coverage not published
Oral / sublingual option listed
MedLeanRx: Yes
Intimate Rose: Yes
Brand-name access listed
MedLeanRx: Yes
Intimate Rose: Not confirmed
Provider facts checked
MedLeanRx: August 2026
Intimate Rose: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MedLeanRx

Texas residents who want a named supervising physician and a brand-name option alongside compounded GLP-1s.

Reasons to consider it

  • Named supervising physician (Dr. Johnson Uzor, MD) publicly disclosed with a dedicated bio page
  • Both compounded semaglutide (injectable and oral tablet) and a brand Wegovy/Zepbound/Foundayo pathway offered on one platform
  • Flat pricing with no dose-tier escalation disclosed

What to weigh up

  • Texas only — not available in any other state
  • Compounding pharmacy is never named anywhere on the site
  • The Terms & Conditions state 'All sales are final' — no refund policy

Intimate Rose

Existing Intimate Rose customers who want to evaluate its OpenLoop-supported weight-management program and will compare the exact prescribed plan.

Reasons to consider it

  • Names OpenLoop Health as the clinical and pharmacy network
  • Lists compounded semaglutide and tirzepatide, including oral options
  • Says provider review, medication, delivery and check-ins are included

What to weigh up

  • The $169 starting price is program-wide, with no separate drug or dose pricing
  • The individual prescriber and dispensing pharmacy are not named before assessment
  • No treatment-specific state list, prescription refund rule or renewal cancellation deadline is published

Regulatory note: the FDA issued a warning letter to Intimate Rose in September 2025. We still list and link to Intimate Rose; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MedLeanRxIntimate Rose
Normalized Cost/Month
MedLeanRx:
31/100
Intimate Rose:
45/100
Price Transparency
MedLeanRx:
78/100
Intimate Rose:
86/100
Nationwide Access
MedLeanRx:
42/100
Intimate Rose:
24/100
Formulation Options
MedLeanRx:
90/100
Intimate Rose:
77/100
Clinical Oversight
MedLeanRx:
77/100
Intimate Rose:
64/100
Contract Flexibility
MedLeanRx:
47/100
Intimate Rose:
61/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.